FRC
FRC Logo
Sign InGet Access

Connect With Us

Stay updated with our latest research and insights

Fundamental Research Corp Logo

Highly ranked equity research firm providing institutional grade tools and analysis to all investors worldwide. Trusted by global investors for over 20+ years.

20+ Years

Policies

  • Privacy Policy
  • Terms of Service
  • Disclaimer

Company

  • About Us
  • Our Team
  • Contact Us

Resources

  • Videos
  • Research Reports
  • FAQ

© 2026 Fundamental Research Corp. All Rights Reserved.

Professional investment research since 2003

Home
Research
Get Access
Sign In
Aspen Pharmacare Holdings Limited Stock AnalysisComprehensive stock analysis for Aspen Pharmacare Holdings Limited (APNHY) including live price, Snowflake performance metrics, financial statements, and investment research.Stock AnalysisAPNHY
APNHY
Aspen Pharmacare Holdings Limited
  • Company Overview
  • FRC Research
  • Financial Data
  • Peer Comparison
  • Ownership & News
APNHY
Home🔹Stocks🔹Aspen Pharmacare Holdings Limited

Aspen Pharmacare Holdings Limited

APNHY•OTC

Aspen Pharmacare Holdings Limited

APNHY•OTC
Market cap
$3.72B
Sentiment

Your view on APNHY

Mkt Cap
$3.72B
Sentiment
Your view
APNHY
Aspen Pharmacare Holdings Limited
  • Company Overview
  • FRC Research
  • Financial Data
  • Peer Comparison
  • Ownership & News
APNHY
Company Overview

Overview

What the company does, where it operates, and who runs it.

About Aspen Pharmacare Holdings Limited

Industry
Drug Manufacturers - Specialty & Generic
Sector
Healthcare
CEO
Stephen Bradley Saad
Headquarters
Aspen Place, Durban, ZA
Industry
Drug Manufacturers - Specialty & Generic
Sector
Healthcare
CEO
Stephen Bradley Saad
Headquarters
Aspen Place, Durban, ZA
Description

Aspen Pharmacare Holdings Limited, together with its subsidiaries, manufactures and supplies specialty and branded pharmaceutical products worldwide. It operates in Commercial Pharmaceuticals and Manufacturing segments. The company provides general anesthetics, muscle relaxants, and topical agents under the Anaesthetics brand; and a range of injectable anticoagulants with a focus on low molecular weight heparins, Xa inhibitors, and heparin derivatives under the Thrombosis brand. It also offers branded consumer, prescription, and over-the-counter products under the regional brands, such as Circadin, Foxair, Maltofer, Mybulen, and Zyloric for various types of anesthetic comprises sleeping aid, respiratory, iron supplement, analgesic, and uric acid production inhibitor. In addition, the company manufactures and sells active pharmaceutical ingredients and finished dose form products to third-party customers. The company was founded in 1850 and is headquartered in Durban, South Africa.

Infographics

Visual summary of the business at a glance.

FRC Research

Media

Videos and interviews covering the company.

Financial Data

Stock Data

Price chart, volume, and trading data.

Fair Value

What FRC thinks the stock is worth vs. the current price.

Financial Ratios

Profitability, returns, valuation, and leverage ratios.

Dividend Analysis

Yield, payout ratio, and dividend coverage metrics.

Earnings Analysis

EPS history, beat rate, and upcoming earnings reports.

Financial Statements

Income statement, balance sheet, and cash flow statements.

Peer Comparison

Comparables

List of peer companies in the same industry.

Ownership & News

Institutional Ownership

Which funds and firms own the stock.

Insider Trading

Recent buying and selling by company executives.

Senate Trading

U.S. Senator disclosures filed under the STOCK Act.

News

Latest headlines and market coverage.

News

Latest Market News